홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TENX
#2544
Tenax Therapeutics, Inc.
12.000
0
-0.41%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.41%
월간 변동
-19.46%
6달 변화
+58.94%
년간 변동율
+58.94%
이전 종가
12.050
0
Open
12.000
0
Bid
Ask
Low
12.000
0
High
12.000
0
양
13
마켓
주식
헬스케어
TENX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
3.41 M
3.97 M
4.15 M
4.56 M
6.24 M
—
Valuation ratios
Enterprise value
11.3 M
-70.32 M
-84.23 M
-79.22 M
-51.89 M
-285.66 M
Price to earnings ratio
—
-5.38
—
—
2.52
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
6.39
—
—
9.41
—
Price to book ratio
—
1.03
—
—
0.54
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.04
-0.06
-0.09
-0.1
-0.15
-0.41
Return on equity %
0.04
-0.07
-0.1
-0.1
-0.16
-0.43
Return on invested capital %
—
-2.24
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
38.95
20.6
40.48
41.89
15.58
118.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.23
-0.19
-0.16
-0.24
-0.82
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.07
3.04
2.77
2.57
8.45
Net current asset value per share
—
6.33
3.06
2.78
2.66
14.83
Tangible book value per share
—
6.02
2.99
2.71
2.49
14.21
Working capital per share
—
6.02
2.99
2.71
2.49
14.21
Book value per share
—
6.02
2.99
2.71
2.49
14.21
뉴스
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)
Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)
Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing
Tesla, Goldman Sachs among market cap stock movers on Monday
테낙스 테라퓨틱스, 3상 LEVEL 연구 등록 목표 확인
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target
Tenax Therapeutics 목표 주가, Guggenheim, 14달러에서 25달러로 상향
Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim
테낙스 테라퓨틱스 이사 Rich Stuart, 50,792달러 상당의 주식 매입
Tenax Therapeutics director Rich Stuart buys $50,792 in stock
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999
Tenax Therapeutics 임시 CFO, 58,164달러 상당 주식 매입